Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-27

FDA Approved: RANITIDINE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA Inc.'s Original Application for ranitidine, a generic H2 blocker, with label indications including treatment of duodenal ulcers, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranitidine (Ranitidine)

Snippet

ORIG AP for RANITIDINE (RANITIDINE)